Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaB-cell neoplasm, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, digestive system disorder, high grade B-cell lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, pyloric stenosis, stomach disorderRecruitingEarly phase 12026-02-17NCT04512716

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Memorial Sloan Kettering Cancer Center753

7 results · Page 1 of 1